rs531602219
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_024847.4(TMC7):c.61C>G(p.His21Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000226 in 1,502,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024847.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMC7 | ENST00000304381.10 | c.61C>G | p.His21Asp | missense_variant | Exon 1 of 16 | 1 | NM_024847.4 | ENSP00000304710.5 | ||
TMC7 | ENST00000569532.5 | c.61C>G | p.His21Asp | missense_variant | Exon 1 of 15 | 2 | ENSP00000455041.1 | |||
TMC7 | ENST00000568469.5 | n.102C>G | non_coding_transcript_exon_variant | Exon 1 of 10 | 2 | |||||
TMC7 | ENST00000421369.3 | c.-721C>G | upstream_gene_variant | 1 | ENSP00000397081.3 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152188Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000201 AC: 2AN: 99548 AF XY: 0.0000360 show subpopulations
GnomAD4 exome AF: 0.0000156 AC: 21AN: 1350018Hom.: 0 Cov.: 30 AF XY: 0.0000150 AC XY: 10AN XY: 665808 show subpopulations
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152296Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74468 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.61C>G (p.H21D) alteration is located in exon 1 (coding exon 1) of the TMC7 gene. This alteration results from a C to G substitution at nucleotide position 61, causing the histidine (H) at amino acid position 21 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at